These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24266348)

  • 1. The ron receptor tyrosine kinase: a key regulator of inflammation and cancer progression.
    Wang X; Hankey PA
    Crit Rev Immunol; 2013; 33(6):549-74. PubMed ID: 24266348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression.
    Sullivan C; Brown NE; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
    Mol Cancer Res; 2020 Aug; 18(8):1244-1254. PubMed ID: 32439702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells.
    Wang MH; Lee W; Luo YL; Weis MT; Yao HP
    J Pathol; 2007 Dec; 213(4):402-11. PubMed ID: 17955509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.
    Wagh PK; Peace BE; Waltz SE
    Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.
    Kretschmann KL; Eyob H; Buys SS; Welm AL
    Curr Drug Targets; 2010 Sep; 11(9):1157-68. PubMed ID: 20545605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase.
    Sharda DR; Yu S; Ray M; Squadrito ML; De Palma M; Wynn TA; Morris SM; Hankey PA
    J Immunol; 2011 Sep; 187(5):2181-92. PubMed ID: 21810604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
    Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic signaling pathways activated by RON receptor tyrosine kinase.
    Danilkovitch-Miagkova A
    Curr Cancer Drug Targets; 2003 Feb; 3(1):31-40. PubMed ID: 12570659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
    Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
    Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
    Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
    Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.
    Eyob H; Ekiz HA; Derose YS; Waltz SE; Williams MA; Welm AL
    Cancer Discov; 2013 Jul; 3(7):751-60. PubMed ID: 23612011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RON Signaling Is a Key Mediator of Tumor Progression in Many Human Cancers.
    Faham N; Welm AL
    Cold Spring Harb Symp Quant Biol; 2016; 81():177-188. PubMed ID: 28057847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein.
    Wang MH; Montero-Julian FA; Dauny I; Leonard EJ
    Oncogene; 1996 Nov; 13(10):2167-75. PubMed ID: 8950984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member.
    O'Toole JM; Rabenau KE; Burns K; Lu D; Mangalampalli V; Balderes P; Covino N; Bassi R; Prewett M; Gottfredsen KJ; Thobe MN; Cheng Y; Li Y; Hicklin DJ; Zhu Z; Waltz SE; Hayman MJ; Ludwig DL; Pereira DS
    Cancer Res; 2006 Sep; 66(18):9162-70. PubMed ID: 16982759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ron-receptor tyrosine kinase in tumorigenesis and metastasis.
    Leonis MA; Thobe MN; Waltz SE
    Future Oncol; 2007 Aug; 3(4):441-8. PubMed ID: 17661719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway.
    Xiangming X; Yun Q; Guoliang Z; Jianjiang L; Lisong T
    Braz J Med Biol Res; 2011 Jul; 44(7):634-41. PubMed ID: 21655705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of RON in small and non-small cell lung cancers.
    Kanteti R; Krishnaswamy S; Catenacci D; Tan YH; EL-Hashani E; Cervantes G; Husain AN; Tretiakova M; Vokes EE; Huet H; Salgia R
    Genes Chromosomes Cancer; 2012 Sep; 51(9):841-51. PubMed ID: 22585712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.
    Yao HP; Zhou YQ; Ma Q; Guin S; Padhye SS; Zhang RW; Wang MH
    Mol Cancer; 2011 Jul; 10():82. PubMed ID: 21749705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.